Neuroblastoma Update

Coordinated by Sue Cohn and Andy Pearson

The Update Courses have proved to be extremely valuable for clinical fellows‐in‐training to obtain an overview of the latest research advances, and similarly, for laboratory researchers to have an overview of the latest clinical approaches. On this occasion, we anticipate that the Update Course will also be attended by “general” paediatric oncologists (non‐ neuroblastoma specialists) and other health care providers (including particularly nurses) who will be attending ANZCHOG as well as participants of ANR 2016. In addition, parents who will be attending the Neuroblastoma Parents Day which is scheduled on Friday may attend the Course.


To address the needs of the audience, we are asking speakers to provide a state‐of‐the‐art overview of their topics. The Update Course will be held during the last day of the ANR meeting, and speakers will be encouraged to include relevant, exciting new data presented during the ANR meeting.

Thursday June 23rd

Time

Title

    Speaker

11:00 – 11:20

Overview of neuroblastoma epidemiology and genetic predisposition

Dr Sharon Diskin
Children's Hospital of Philadelphia, USA

11:20 – 11:40

Actionable genomic mutations

Dr Frank Speleman
Cancer Research Institute Ghent, Belgium

11:40 – 12:00

INRG Risk Classification/ database

Prof Sue Cohn
University of Chicago, USA; and
Prof Andy Pearson
Institute of Cancer Research UK

12:00– 12:30

Overview of treatment for low- and intermediate-risk patients

Dr Gudrun Schleiermacher
Institut Curie, France

12:30 -13:30

LUNCH BREAK

13:30 – 14:00

Overview of treatment for high-risk patients

Dr Julie Park
Seattle Children’s Hospital, USA

14:00 – 14:30

Overview of treatment for relapsed disease

Dr Lucas Moreno
Spanish National Cancer Research Center, Spain

14:30– 15:00

Long-term effect of treatment

Dr Lisa Diller
Dana Farber Cancer Institute, USA